Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001078750 | SCV000752850 | likely benign | Long QT syndrome | 2022-12-06 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000755801 | SCV000883380 | likely benign | not provided | 2018-06-04 | criteria provided, single submitter | clinical testing | The p.Glu2332Glu variant does not alter the amino acid sequence of the AKAP9 protein and computational splice site prediction algorithms do not predict a change in the nearest splice site or creation of a cryptic splice site. This variant has not been reported in association with long QT syndrome in medical literature or in gene specific variation databases. It is absent from general population databases such as 1000 Genomes, NHLBI GO Exome Sequencing Project (ESP), and the Genome Aggregation Database (gnomAD). Based on these observations, the p.Glu2332Glu variant is likely to be benign. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002307565 | SCV002600829 | likely benign | not specified | 2022-10-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002360508 | SCV002665175 | likely benign | Cardiovascular phenotype | 2022-05-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |